Related references
Note: Only part of the references are listed.TBX4 variants and pulmonary diseases: getting out of the 'Box'
Meindina G. Haarman et al.
CURRENT OPINION IN PULMONARY MEDICINE (2020)
Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study
Maria C. Magnus et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Novel risk genes and mechanisms implicated by exome sequencing of 2572 individuals with pulmonary arterial hypertension
Na Zhu et al.
GENOME MEDICINE (2019)
Therapy for Pulmonary Arterial Hypertension in Adults Update of the CHEST Guideline and Expert Panel Report
James R. Klinger et al.
CHEST (2019)
Widening the landscape of heritable pulmonary hypertension mutations in paediatric and adult cases
Melanie Eyries et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Genetics and genomics of pulmonary arterial hypertension
Nicholas W. Morrell et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
Gerald Simonneau et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Risk stratification and medical therapy of pulmonary arterial hypertension
Nazzareno Galie et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
United States Pulmonary Hypertension Scientific Registry (USPHSR): rationale, design, and clinical implications
C. Gregory Elliott et al.
PULMONARY CIRCULATION (2019)
Targeting the Prostacyclin Pathway with Selexipag in Patients with Pulmonary Arterial Hypertension Receiving Double Combination Therapy: Insights from the Randomized Controlled GRIPHON Study
J. Gerry Coghlan et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2018)
Identification of rare sequence variation underlying heritable pulmonary arterial hypertension
Stefan Graf et al.
NATURE COMMUNICATIONS (2018)
Rare variants in SOX17 are associated with pulmonary arterial hypertension with congenital heart disease
Na Zhu et al.
GENOME MEDICINE (2018)
Exome Sequencing in Children With Pulmonary Arterial Hypertension Demonstrates Differences Compared With Adults
Na Zhu et al.
CIRCULATION-GENOMIC AND PRECISION MEDICINE (2018)
Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study
David Montani et al.
LANCET RESPIRATORY MEDICINE (2017)
Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension
Charaka Hadinnapola et al.
CIRCULATION (2017)
BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis
Jonathan D. W. Evans et al.
LANCET RESPIRATORY MEDICINE (2016)
Effects of Maternal Age and Age-Specific Preterm Birth Rates on Overall Preterm Birth Rates - United States, 2007 and 2014
Cynthia Ferre et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2016)
Selexipag for the Treatment of Pulmonary Arterial Hypertension
Olivier Sitbon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
N. Galie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Progress in solving the sex hormone paradox in pulmonary hypertension
Tim Lahm et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2014)
EIF2AK4 Mutations in Pulmonary Capillary Hemangiomatosis
D. Hunter Best et al.
CHEST (2014)
EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension
Melanie Eyries et al.
NATURE GENETICS (2014)
TBX4 mutations (small patella syndrome) are associated with childhood-onset pulmonary arterial hypertension
Wilhelmina S. Kerstjens-Frederikse et al.
JOURNAL OF MEDICAL GENETICS (2013)
Definitions and Diagnosis of Pulmonary Hypertension
Marius M. Hoeper et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension
Tomas Pulido et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
A Novel Channelopathy in Pulmonary Arterial Hypertension
Lijiang Ma et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Riociguat for the Treatment of Pulmonary Arterial Hypertension
Hossein-Ardeschir Ghofrani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients on Background Endothelin Receptor Antagonist and/or Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C Study) A Randomized Controlled Trial
Victor E. Tapson et al.
CHEST (2012)
An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry
Raymond L. Benza et al.
CHEST (2012)
Whole Exome Sequencing to Identify a Novel Gene (Caveolin-1) Associated With Human Pulmonary Arterial Hypertension
Eric D. Austin et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2012)
Molecular genetics and clinical features of Chinese idiopathic and heritable pulmonary arterial hypertension patients
D. Liu et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
The Value of Statistical Analysis Plans in Observational Research Defining High-Quality Research From the Start
Laine Thomas et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
REVEAL: a contemporary US pulmonary arterial hypertension registry
M. D. McGoon et al.
EUROPEAN RESPIRATORY REVIEW (2012)
The Changing Picture of Patients With Pulmonary Arterial Hypertension in the United States How REVEAL Differs From Historic and Non-US Contemporary Registries
Adaani E. Frost et al.
CHEST (2011)
Pulmonary Arterial Hypertension Baseline Characteristics From the REVEAL Registry
David B. Badesch et al.
CHEST (2010)
International, prospective register for the documentation of first-line and maintenance therapy in patients with pulmonary hypertension (CompERA-XL)
D. Pittrow et al.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2009)
A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension
M. Shintani et al.
JOURNAL OF MEDICAL GENETICS (2009)
Updated Clinical Classification of Pulmonary Hypertension
Gerald Simonneau et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Miscarriage and its associations
Stephen Brown
SEMINARS IN REPRODUCTIVE MEDICINE (2008)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
Erik von Elm et al.
LANCET (2007)
Pulmonary arterial hypertension in France - Results from a national registry
M Humbert et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia
RE Harrison et al.
JOURNAL OF MEDICAL GENETICS (2003)
Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia
RC Trembath et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene
ZM Deng et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension
KB Lane et al.
NATURE GENETICS (2000)
Share Paper
